Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors
Condition: Malignant Neoplasm Interventions: Drug: Decitabine; Biological: DC-CIK Sponsor: Li Yu Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials